Dong Liying, Hu Shasha, Gao Jianjun
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒于2019年12月出现，随后在全球迅速传播，尤其是在中国、日本和韩国。科学家们正在努力寻找针对该病毒的抗病毒药物。目前，氯喹、阿比多尔、瑞德西韦和法匹拉韦等几种药物正在中国进行临床试验，以测试它们在治疗2019冠状病毒病（COVID-19）中的疗效和安全性；到目前为止已经取得了一些有希望的结果。本文总结了对SARS-CoV-2具有潜在疗效的药物。
